换一批
换一批
第一作者：
Akinyemi I,Ojesina
第一单位：
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3].
作者：
Akinyemi I,Ojesina [1]
;
Lee,Lichtenstein [2]
;
Samuel S,Freeman [3]
;
Chandra Sekhar,Pedamallu [4]
;
Ivan,Imaz-Rosshandler [5]
;
Trevor J,Pugh [4]
;
Andrew D,Cherniack [3]
;
Lauren,Ambrogio [3]
;
Kristian,Cibulskis [3]
;
Bjørn,Bertelsen [6]
;
Sandra,Romero-Cordoba [5]
;
Victor,Treviño [7]
;
Karla,Vazquez-Santillan [5]
;
Alberto Salido,Guadarrama [5]
;
Alexi A,Wright [8]
;
Mara W,Rosenberg [3]
;
Fujiko,Duke [9]
;
Bethany,Kaplan [4]
;
Rui,Wang [10]
;
Elizabeth,Nickerson [3]
;
Heather M,Walline [11]
;
Michael S,Lawrence [3]
;
Chip,Stewart [3]
;
Scott L,Carter [3]
;
Aaron,McKenna [3]
;
Iram P,Rodriguez-Sanchez [12]
;
Magali,Espinosa-Castilla [5]
;
Kathrine,Woie [13]
;
Line,Bjorge [14]
;
Elisabeth,Wik [14]
;
Mari K,Halle [14]
;
Erling A,Hoivik [14]
;
Camilla,Krakstad [14]
;
Nayeli Belem,Gabiño [5]
;
Gabriela Sofia,Gómez-Macías [12]
;
Lezmes D,Valdez-Chapa [12]
;
María Lourdes,Garza-Rodríguez [12]
;
German,Maytorena [15]
;
Jorge,Vazquez [15]
;
Carlos,Rodea [15]
;
Adrian,Cravioto [15]
;
Maria L,Cortes [3]
;
Heidi,Greulich [16]
;
Christopher P,Crum [17]
;
Donna S,Neuberg [18]
;
Alfredo,Hidalgo-Miranda [5]
;
Claudia Rangel,Escareno [19]
;
Lars A,Akslen [20]
;
Thomas E,Carey [21]
;
Olav K,Vintermyr [20]
;
Stacey B,Gabriel [3]
;
Hugo A,Barrera-Saldaña [12]
;
Jorge,Melendez-Zajgla [5]
;
Gad,Getz [22]
;
Helga B,Salvesen [23]
;
Matthew,Meyerson [24]
作者单位：
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3].
[1]
1] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [2].
[2]
The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
[3]
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
[4]
Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
[5]
Department of Pathology, Haukeland University Hospital, N5021 Bergen, Norway.
[6]
Tecnológico de Monterrey, Monterrey 64849, Mexico.
[7]
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
[8]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
[9]
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
[10]
Cancer Biology Program, Program in the Biomedical Sciences, Rackham Graduate School, University of Michigan, Ann Arbor, Michigan 48109, USA.
[11]
Facultad de Medicina y Hospital Universitario 'Dr. José Eluterio González' de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
[12]
Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway.
[13]
1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway.
[14]
Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
[15]
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
[16]
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
[17]
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
[18]
1] Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico [2] Claremont Graduate University, Claremont, California 91711, USA.
[19]
1] Department of Pathology, Haukeland University Hospital, N5021 Bergen, Norway [2] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, N5020 Bergen, Norway.
[20]
Head and Neck Oncology Program and Department of Otolaryngology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 38109, USA.
[21]
1] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [2] Massachusetts General Hospital Cancer Center and Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
[22]
1] Department of Obstetrics and Gynecology, Haukeland University Hospital, N5021 Bergen, Norway [2] Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway [3].
[23]
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [4].
[24]
主题词
腺癌(Adenocarcinoma);癌, 鳞状细胞(Carcinoma, Squamous Cell);病例对照研究(Case-Control Studies);细胞周期蛋白质类(Cell Cycle Proteins);核心结合因子β亚基(Core Binding Factor beta Subunit);DNA拷贝数变异(DNA Copy Number Variations);DNA突变分析(DNA Mutational Analysis);DNA结合蛋白质类(DNA-Binding Proteins);E1A相关p300蛋白质(E1A-Associated p300 Protein);F框蛋白质类(F-Box Proteins);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因组, 人(Genome, Human);基因组学(Genomics);HLA-B抗原(HLA-B Antigens);人类(Humans);丝裂原活化蛋白激酶1(Mitogen-Activated Protein Kinase 1);突变(Mutation);NF-E2相关因子2(NF-E2-Related Factor 2);乳头状瘤病毒科(Papillomaviridae);乳头状瘤病毒感染(Papillomavirus Infections);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质c-ets(Proto-Oncogene Proteins c-ets);转录因子(Transcription Factors);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53);泛素蛋白连接酶类(Ubiquitin-Protein Ligases);宫颈肿瘤(Uterine Cervical Neoplasms);病毒整合(Virus Integration)
DOI
10.1038/nature12881
PMID
24390348
发布时间
2022-04-09
- 浏览209
Nature
Nature
371-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
